These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6736871)

  • 21. Importance of the antigen-binding valency and the nature of the cross-linking bond in ricin A-chain conjugates with antibody.
    Masuho Y; Kishida K; Saito M; Umemoto N; Hara T
    J Biochem; 1982 May; 91(5):1583-91. PubMed ID: 7096308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyclonal anti-idiotypes induce antibody responses protective against ricin cytotoxicity.
    Chanh TC; Hewetson JF
    Immunology; 1993 Aug; 79(4):681-4. PubMed ID: 8406596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytotoxicity of a conjugate of ricin A-chain and monoclonal anti-allotypic antibody].
    Rachmanova VA; Tonevitskiĭ AG; Cherapakhin VV; Bobreneva RA
    Biull Eksp Biol Med; 1988 May; 105(5):568-70. PubMed ID: 3132992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic amines.
    Casellas P; Ravel S; Bourrié BJ; Derocq JM; Jansen FK; Laurent G; Gros P
    Blood; 1988 Oct; 72(4):1197-202. PubMed ID: 3262384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody.
    Blakey DC; Watson GJ; Knowles PP; Thorpe PE
    Cancer Res; 1987 Feb; 47(4):947-52. PubMed ID: 3492271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion molecule.
    Derbyshire EJ; Stahel RA; Wawrzynczak EJ
    Clin Exp Immunol; 1992 Sep; 89(3):336-40. PubMed ID: 1325302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preparation of an anti-human immunotoxin against bladder carcinoma and its in vitro targeting cytotoxicity].
    Zhao C
    Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):109-11. PubMed ID: 1618077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-Exposure Anti-Ricin Treatment Protects Swine Against Lethal Systemic and Pulmonary Exposures.
    Falach R; Sapoznikov A; Evgy Y; Aftalion M; Makovitzki A; Agami A; Mimran A; Lerer E; Ben David A; Zichel R; Katalan S; Rosner A; Sabo T; Kronman C; Gal Y
    Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32481526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor.
    Kishimoto T; Ishizaka K
    J Immunol; 1975 Feb; 114(2 Pt 1):585-91. PubMed ID: 1079034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Target-cell cytotoxicity of a hybrid of Fab' on immunoglobulin and A-chain of ricin.
    Masuho Y; Hara T
    Gan; 1980 Dec; 71(6):759-65. PubMed ID: 7274624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
    Pietersz GA; Kanellos J; McKenzie IF
    Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active immunity induced by passive IgG post-exposure protection against ricin.
    Hu CC; Yin J; Chau D; Cherwonogrodzky JW; Hu WG
    Toxins (Basel); 2014 Jan; 6(1):380-93. PubMed ID: 24451844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human antibody responses to components of the monoclonal antimelanoma antibody ricin A chain immunotoxin XomaZyme-MEL.
    Mischak RP; Foxall C; Rosendorf LL; Knebel K; Scannon PJ; Spitler LE
    Mol Biother; 1990 Jun; 2(2):104-9. PubMed ID: 2363853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.
    Colombatti M; Johnson VG; Skopicki HA; Fendley B; Lewis MS; Youle RJ
    J Immunol; 1987 May; 138(10):3339-44. PubMed ID: 2437188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Selective cytotoxicity of antibody-ricin-A-chain conjugate for human tumor B cells. II. Comparison of activity of immunotoxins conjugated with poly- and monoclonal antibodies].
    Tonevitskiĭ AG; Zhukova OS; Rakhmanova VA; Arsen'eva EL; Bogacheva GT
    Mol Biol (Mosk); 1988; 22(4):911-6. PubMed ID: 3141780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.